Parallax Volatility Advisers, L.P. Glaukos Corp Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $1.3 Million - $2.3 Million	27,336 New	27,336 $1.32 Million
Q2 2019 Aug 14, 2019	SELL	$63.59 - $78.71 $127,180 - $157,420	-2,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $101,500 - $161,080	2,000 New	2,000 $157,000
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $4,383 - $5,706	-84 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$38.13 - $68.37 $163,348 - $292,897	-4,284 Reduced 98.08%	84 $5,000
Q4 2017 Feb 14, 2018	BUY	$24.5 - $36.01 $107,016 - $157,291	4,368	4,368 $112,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.